| 1 |
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum
Lucia Nappi et al. · Journal of Clinical Oncology
Open access |
25 Sep 2019 |
127 |
| 2 |
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors
Lucia Nappi, Marisa Thi, Nabil Adra et al. · European Urology
Open access |
4 Nov 2020 |
67 |
| 3 |
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers
Lucia Nappi et al. · The Oncologist
Open access |
31 Jul 2020 |
38 |
| 4 |
MicroRNAs as Biomarkers for Germ Cell Tumors
Lucia Nappi, Craig R. Nichols · Urologic Clinics of North America
|
29 May 2019 |
25 |
| 5 |
The Connection Between Testicular Cancer, Minority Males, and Planned Parenthood
Wesley B. Adams, Michael J. Rovito, Mike Craycraft · American Journal of Men s Health
Open access |
16 Jul 2018 |
10 |
| 6 |
The role of micro-RNAs in management of germ cell tumors: future directions
Lucia Nappi, Christian Kollmannsberger, Craig R. Nichols · Current Opinion in Urology
|
19 Jan 2020 |
9 |
| 7 |
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors
Jack V. W. Bacon, Patrizia Giannatempo, Giovanna Cataldo et al. · The Oncologist
Open access |
27 Sep 2022 |
8 |
| 8 |
Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe
Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Journal of Clinical Oncology
|
10 Jun 2019 |
8 |
| 9 |
A Call to Action to Review the USPSTF’s Recommendation for Testicular Self-Examination
Michael J. Rovito, Keri Allen, Ajay K. Nangia et al. · American Journal of Men s Health
Open access |
Sep 2022 |
7 |
| 10 |
Genomic features of mediastinal germ cell tumors: a narrative review
Güliz Özgün, Craig R. Nichols, Christian Kollmannsberger et al. · Mediastinum
ReviewOpen access |
19 Jul 2022 |
7 |
| 11 |
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer
Xiaosong Meng, Murtaza Ahmed, Kevin Dale Courtney et al. · Frontiers in Oncology
Open access |
7 Oct 2021 |
7 |
| 12 |
Testicular Cancer Incidence and Mortality Within Rural and Urban Regions
Michael J. Rovito, Skyler Taylor, Ryan Lockwood et al. · Journal of Adolescent and Young Adult Oncology
|
Apr 2020 |
6 |
| 13 |
Humor-Based Messaging in Testicular Cancer Awareness Campaigns: A Comparative Critical Review
Michael J. Rovito, Keri Allen, Andres G. Perez et al. · American Journal of Men s Health
Open access |
Nov 2023 |
4 |
| 14 |
Novel treatment options for refractory Germ Cell Tumours: back to the bench!
Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Annals of Oncology
Open access |
16 Nov 2017 |
4 |
| 15 |
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer
Güliz Özgün, Neda Abdalvand, Gizem Özcan et al. · JCO Clinical Cancer Informatics
Open access |
Aug 2025 |
3 |
| 16 |
Narrative review of developing new biomarkers for decision making in advanced testis cancer
Lucia Nappi, Craig R. Nichols, Christian Kollmannsberger · Translational Andrology and Urology
ReviewOpen access |
16 Jun 2021 |
3 |
| 17 |
Back to the Future—Moving Forward for Testicular Cancer Survivors
Craig R. Nichols, Lucia Nappi, Christian Kollmannsberger et al. · JNCI Cancer Spectrum
Open access |
2 Oct 2019 |
3 |
| 18 |
Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors
Craig R. Nichols, Torgrim Tandstad, William Thomas Lowrance et al. · Annals of Oncology
Open access |
9 Dec 2017 |
3 |
| 19 |
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors
Arkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon et al. · PLoS ONE
Open access |
9 May 2025 |
2 |
| 20 |
Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Lawrence H. Einhorn, Nabil Adra, Nasser H. Hanna et al. · Journal of Clinical Oncology
|
7 Jul 2020 |
2 |
| 21 |
Current Practice Patterns Surrounding Fertility Concerns in Stage I Seminoma Patients: Survey of United States Radiation Oncologists
Carl M. Post, Aditya Jain, Catherine Degnin et al. · Journal of Adolescent and Young Adult Oncology
|
16 Jan 2018 |
2 |
| 22 |
First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer.
Lucia Nappi et al. · Journal of Clinical Oncology
|
3 Jun 2026 |
1 |
| 23 |
Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?
Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Clinical Cancer Research
|
13 Nov 2025 |
1 |
| 24 |
A Cross-Sectional Analysis of Testicular Cancer Symptom Recognition and Stage of Diagnosis
Michael J. Rovito, Mike Craycraft, Wesley B. Adams et al. · American Journal of Men s Health
Open access |
May 2022 |
1 |
| 25 |
On thin ice: barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists
Aditya Jain, Catherine Degnin, Yiyi Chen et al. · International braz j urol
Open access |
Jun 2018 |
1 |
| 26 |
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial
Brian Robin Hu et al. · The Journal of Urology
|
9 Apr 2025 |
0 |
| 27 |
Favorable long-term Health Related Quality of Life in cured survivors of testicular cancer management. So, what now?
Anjaline D'Souza, Jennifer M. King, Lucia Nappi et al. · Annals of Oncology
Open access |
Dec 2023 |
0 |
| 28 |
Relato de caso: Tumor testicular bilateral metacrônico
Rafael Scandiuzzi, Rayane Morais Costa, Leticia Alves de Melo · Brazilian Journal of Health Review
Open access |
27 Sep 2022 |
0 |
| 29 |
So, now what?: Reflections on socioeconomic factors, testicular cancer, and health care accessibility
Michael J. Rovito, Mike Craycraft, Walker Talton et al. · Cancer
Open access |
17 Feb 2021 |
0 |
| 30 |
Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer
Lucia Nappi, Marisa Thi, Bernhard J. Eigl et al. · Annals of Oncology
Open access |
Oct 2018 |
0 |
| 31 |
Management of Disseminated Germ Cell Tumor in Adults
Craig R. Nichols, Christopher R. Porter, Christian Kollmannsberger · Pediatric oncology
Book chapter |
3 Aug 2013 |
0 |